Enfusion, Inc. Files 2024 Annual Report Amendment
| Field | Detail |
|---|---|
| Company | Enfusion, Inc. |
| Form Type | 10-K/A |
| Filed Date | Apr 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, software
TL;DR
Enfusion filed its 2024 10-K amendment, check for updates on their software biz.
AI Summary
Enfusion, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, dated April 21, 2025, provides updated information for the company, which is incorporated in Delaware and headquartered in Chicago, Illinois. Enfusion, Inc. operates in the prepackaged software services sector.
Why It Matters
This amendment provides updated financial and operational information for Enfusion, Inc. for the fiscal year 2024, which is crucial for investors and stakeholders to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This filing is an amendment to a standard annual report and does not appear to contain significant new negative information.
Key Numbers
- 001-40949 — SEC File Number (Identifies the company's filings with the SEC.)
- 87-1268462 — IRS Employer Identification No. (Tax identification number for the company.)
Key Players & Entities
- Enfusion, Inc. (company) — Registrant
- 125 South Clark Street, Suite 750, Chicago, IL 60603 (location) — Principal Business Address
- Delaware (location) — State of Incorporation
- December 31, 2024 (date) — Fiscal Year End
- April 21, 2025 (date) — Filing Date
FAQ
What specific changes or updates are detailed in this 10-K/A amendment?
The filing is an amendment to the annual report for the fiscal year ended December 31, 2024, indicating updates to previously submitted information, though the specific details of the changes are not provided in this excerpt.
What is Enfusion, Inc.'s primary business sector?
Enfusion, Inc. is classified under SERVICES-PREPACKAGED SOFTWARE [7372].
When was this amendment filed with the SEC?
This amendment (10-K/A) was filed on April 21, 2025.
Where is Enfusion, Inc. headquartered?
Enfusion, Inc.'s principal business address is 125 South Clark Street, Suite 750, Chicago, IL 60603.
What is the fiscal year end for Enfusion, Inc.?
Enfusion, Inc.'s fiscal year ends on December 31.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 21, 2025 regarding Enfusion, Inc..